Steven Glazer

Chief Tech/Sci/R&D Officer at

Glazer Consulting Holding ApS

78 year

1 connections

Health Technology

Consumer Services

Commercial Services

Profile

Steven Glazer is currently the Chief Medical Officer at MonTa Biosciences ApS, Allero Therapeutics BV, and Glazer Consulting Holding ApS.
Previously, he worked as the Medical Director at Novo Nordisk Scandinavia AB, Independent Director at Mendus AB, Medical Director at RhoVac AB, Senior Vice President-Development at BioInvent International AB, Vice President-Development at Zealand Pharma A, Chief Medical Officer & Vice President at Hansa Biopharma AB, Chief Marketing Officer at Idogen AB, and Chief Medical Officer at Ectin Research AB. He holds a doctorate degree from the University of Copenhagen.

Steven Glazer active positions

Companies	Position	Start
Glazer Consulting Holding ApS	Chief Tech/Sci/R&D Officer	-
MonTa Biosciences ApS MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy	Chief Tech/Sci/R&D Officer	-
Allero Therapeutics BV Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases	Chief Tech/Sci/R&D Officer	-

All active positions of Steven Glazer

Former positions of Steven Glazer

Companies	Position	End
CHOSA ONCOLOGY AB	Corporate Officer/Principal	-
Idogen AB Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases	Sales & Marketing	-
ECTIN RESEARCH AB	Chief Tech/Sci/R&D Officer	-
Novo Nordisk Scandinavia AB Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services	Chief Tech/Sci/R&D Officer	-
ZEALAND PHARMA A/S	Corporate Officer/Principal	-

See the detail of Steven Glazer's experience

Training of Steven Glazer

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Steven Glazer's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	12
BioInvent International AB BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment	Health Technology
Zealand Pharma A/S Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines	Health Technology
University of Copenhagen University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Hansa Biopharma AB Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory	Health Technology
Novo Nordisk Scandinavia AB Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products and services	Health Technology
Mendus AB Mendus AB BiotechnologyHealth Technology Develops immunotherapies for therapeutic treatment of cancer	Health Technology
Idogen AB Idogen AB BiotechnologyHealth Technology Develops cell therapies for treatment of autoimmune diseases	Health Technology
RhoVac AB RhoVac AB BiotechnologyHealth Technology Engages in the research and development of immunotherapy for therapeutic cancer vaccines	Health Technology
MonTa Biosciences ApS MonTa Biosciences ApS BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer immunotherapy	Health Technology
Ectin Research AB Ectin Research AB BiotechnologyHealth Technology Provides cancer therapy research services	Health Technology
Allero Therapeutics BV Allero Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Develops immunotherapy treatment for allergic and autoimmune diseases	Commercial Services
Glazer Consulting Holding ApS